High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.3M
$9,324,784
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $78,550x13 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Zoghbi Huda Y
• Director
10b5-1 Sell
2026-02-19
$1,279,812Largex11
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $1,279,812Largex11 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$1,585,058Largex11
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $1,585,058Largex11 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $77,853x13 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
10b5-1 SellΔOwn -46.8%
2026-01-07
$1,200,000Large
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -46.8%
|
2026-01-07 | $1,200,000Large | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
10b5-1 SellΔOwn -32.9%
2025-11-20
$570,000
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -32.9%
|
2025-11-20 | $570,000 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • VP Controller
Discretionary Sell
2025-11-07
$280,766
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • VP Controller
Discretionary Sell
|
2025-11-07 | $280,766 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
POON CHRISTINE A
• Director
Discretionary Sell
2025-10-29
$4,252,745Largex6
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Discretionary Sell
|
2025-10-29 | $4,252,745Largex6 | S | Form 4 |